Protein kinase C promotes choline transporter‑like protein 1 function via improved cell surface expression in immortalized human hepatic cells

Ishikawa,Takuya; Suwanai,Hirotsugu; Shikuma,Junpei; Suzuki,Ryo; Yamanaka,Tsuyoshi; Odawara,Masato; Inazu,Masato

doi:10.3892/mmr.2019.10894

Protein kinase C promotes choline transporter‑like protein 1 function via improved cell surface expression in immortalized human hepatic cells

Authors:
- Takuya Ishikawa
- Hirotsugu Suwanai
- Junpei Shikuma
- Ryo Suzuki
- Tsuyoshi Yamanaka
- Masato Odawara
- Masato Inazu
View Affiliations

Affiliations: Department of Diabetes, Metabolism and Endocrinology, Tokyo Medical University, Tokyo 160‑0023, Japan, Department of Molecular Preventive Medicine, Tokyo Medical University, Tokyo 160‑8402, Japan
Published online on: December 18, 2019 https://doi.org/10.3892/mmr.2019.10894
Pages: 777-785

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Choline is used to synthesize phospholipids and a lack of choline induces a number of liver‑related diseases, including non‑alcoholic steatohepatitis. The current study characterized the choline uptake system, at molecular and functional levels, in the immortalized human hepatic cell line, Fa2N‑4, to identify the specific choline transporter involved in choline uptake. The present study also assesed whether choline deficiency or the inhibited choline uptake affected cell viability and apoptosis. Reverse transcription‑quantitative polymerase chain reaction (PCR) revealed choline transporter‑like protein 1 (CTL1) and CTL2 mRNA and protein expression in Fa2N‑4 cells. [Methyl‑3H]choline studies revealed choline uptake was saturable and mediated by a single transport system that functioned in a Na+‑independent but pH‑dependent manner, which was similar to CTL1. Hemicholinium‑3 (HC‑3), which is a choline uptake inhibitor, and choline deficiency inhibited cell viability, increased caspase‑3 and ‑7 activities, and increased fluorescein isothiocyanate‑Annexin V immunofluorescent staining indicated apoptosis. Immunofluorescent staining also revealed CTL1 and CTL2 localized in plasma and mitochondrial membranes, respectively. [Methyl‑3H]choline uptake was enhanced by a protein kinase C (PKC) activator, phorbol‑12‑myristate 13‑acetate (PMA). Immunofluorescence staining and western blot analysis demonstrated increased CTL1 expression on the cell membrane following PMA treatment. The results of current study indicated that extracellular choline is primarily transported via CTL1, relying on a direct H+ gradient that functions as a driving force in Fa2N‑4 cells. Furthermore, it was hypothesized that CTL1 and the choline uptake system are strongly associated with cell survival, and that the choline uptake system is modulated by PKC signaling via increased CTL1 expression on the cell surface. These findings provide further insights into the pathogenesis of liver disease involving choline metabolism.

View Figures

View References

1	Michel V, Yuan Z, Ramsubir S and Bakovic M: Choline transport for phospholipid synthesis. Exp Biol Med (Maywood). 231:490–504. 2006. View Article : Google Scholar : PubMed/NCBI
2	Okuda T, Haga T, Kanai Y, Endou H, Ishihara T and Katsura I: Identification and characterization of the high-affinity choline transporter. Nat Neurosci. 3:120–125. 2000. View Article : Google Scholar : PubMed/NCBI
3	Koepsell H, Lips K and Volk C: Polyspecific organic cation transporters: Structure, function, physiological roles, and biopharmaceutical implications. Pharm Res. 24:1227–1251. 2007. View Article : Google Scholar : PubMed/NCBI
4	Traiffort E, Ruat M, O'Regan S and Meunier FM: Molecular characterization of the family of choline transporter-like proteins and their splice variants. J Neurochem. 92:1116–1125. 2005. View Article : Google Scholar : PubMed/NCBI
5	Nakamura T, Fujiwara R, Ishiguro N, Oyabu M, Nakanishi T, Shirasaka Y, Maeda T and Tamai I: Involvement of choline transporter-like proteins, CTL1 and CTL2, in glucocorticoid-induced acceleration of phosphatidylcholine synthesis via increased choline uptake. Biol Pharm Bull. 33:691–696. 2010. View Article : Google Scholar : PubMed/NCBI
6	Robinson MB: Regulated trafficking of neurotransmitter transporters: Common notes but different melodies. J Neurochem. 80:1–11. 2002. View Article : Google Scholar : PubMed/NCBI
7	Fullerton MD, Wagner L, Yuan Z and Bakovic M: Impaired trafficking of choline transporter-like protein-1 at the plasma membrane and inhibition of choline transport in THP-1 monocyte-derived macrophages. Am J Physiol Cell Physiol. 290:C1230–C1238. 2006. View Article : Google Scholar : PubMed/NCBI
8	Schenkel LC, Sivanesan S, Zhang J, Wuyts B, Taylor A, Verbrugghe A and Bakovic M: Choline supplementation restores substrate balance and alleviates complications of Pcyt2 deficiency. J Nutr Biochem. 26:1221–1234. 2015. View Article : Google Scholar : PubMed/NCBI
9	Michel V and Bakovic M: The ubiquitous choline transporter SLC44A1. Cent Nerv Syst Agents Med Chem. 12:70–81. 2012. View Article : Google Scholar : PubMed/NCBI
10	Butler LM, Arning E, Wang R, Bottiglieri T, Govindarajan S, Gao YT and Yuan JM: Prediagnostic levels of serum one-carbon metabolites and risk of hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev. 22:1884–1893. 2013. View Article : Google Scholar : PubMed/NCBI
11	Ghoshal AK and Farber E: The induction of liver cancer by dietary deficiency of choline and methionine without added carcinogens. Carcinogenesis. 5:1367–1370. 1984. View Article : Google Scholar : PubMed/NCBI
12	Rinella ME, Elias MS, Smolak RR, Fu T, Borensztajn J and Green RM: Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet. J Lipid Res. 49:1068–1076. 2008. View Article : Google Scholar : PubMed/NCBI
13	Nishiyama R, Nagashima F, Iwao B, Kawai Y, Inoue K, Midori A, Yamanaka T, Uchino H and Inazu M: Identification and functional analysis of choline transporter in tongue cancer: A novel molecular target for tongue cancer therapy. J Pharmacol Sci. 131:101–109. 2016. View Article : Google Scholar : PubMed/NCBI
14	Haubrich DR and Gerber NH: Choline dehydrogenase. Assay, properties and inhibitors. Biochem Pharmacol. 30:2993–3000. 1981. View Article : Google Scholar : PubMed/NCBI
15	Wiedeman AM, Dyer RA, Green TJ, Xu Z, Barr SI, Innis SM and Kitts DD: Variations in plasma choline and metabolite concentrations in healthy adults. Clin Biochem. 60:77–83. 2018. View Article : Google Scholar : PubMed/NCBI
16	Apparsundaram S, Ferguson SM, George AL Jr and Blakely RD: Molecular cloning of a human, hemicholinium-3-sensitive choline transporter. Biochem Biophys Res Commun. 276:862–867. 2000. View Article : Google Scholar : PubMed/NCBI
17	Burckhardt G and Wolff NA: Structure of renal organic anion and cation transporters. Am J Physiol Renal Physiol. 278:F853–F866. 2000. View Article : Google Scholar : PubMed/NCBI
18	Gründemann D, Liebich G, Kiefer N, Köster S and Schömig E: Selective substrates for non-neuronal monoamine transporters. Mol Pharmacol. 56:1–10. 1999. View Article : Google Scholar : PubMed/NCBI
19	Kouji H, Inazu M, Yamada T, Tajima H, Aoki T and Matsumiya T: Molecular and functional characterization of choline transporter in human colon carcinoma HT-29 cells. Arch Biochem Biophys. 483:90–98. 2009. View Article : Google Scholar : PubMed/NCBI
20	Uchida Y, Inazu M, Takeda H, Yamada T, Tajima H and Matsumiya T: Expression and functional characterization of choline transporter in human keratinocytes. J Pharmacol Sci. 109:102–109. 2009. View Article : Google Scholar : PubMed/NCBI
21	Nagashima F, Nishiyama R, Iwao B, Kawai Y, Ishii C, Yamanaka T, Uchino H and Inazu M: Molecular and functional characterization of choline transporter-like proteins in esophageal cancer cells and potential therapeutic targets. Biomol Ther. 26:399–408. 2018. View Article : Google Scholar
22	Inazu M, Yamada T, Kubota N and Yamanaka T: Functional expression of choline transporter-like protein 1 (CTL1) in small cell lung carcinoma cells: A target molecule for lung cancer therapy. Pharmacol Res. 76:119–131. 2013. View Article : Google Scholar : PubMed/NCBI
23	Yara M, Iwao B, Hara N, Yamanaka T, Uchino H and Inazu M: Molecular and functional characterization of choline transporter in the human trophoblastic cell line JEG-3 cells. Placenta. 36:631–637. 2015. View Article : Google Scholar : PubMed/NCBI
24	Kaplan CP, Porter RK and Brand MD: The choline transporter is the major site of control of choline oxidation in isolated rat liver mitochondria. FEBS Lett. 321:24–26. 1993. View Article : Google Scholar : PubMed/NCBI
25	Zhang XH, Zhao C and Ma ZA: The increase of cell-membranous phosphatidylcholines containing polyunsaturated fatty acid residues induces phosphorylation of p53 through activation of ATR. J Cell Sci. 120:4134–4143. 2007. View Article : Google Scholar : PubMed/NCBI
26	Cai H, Erhardt P, Troppmair J, Diaz-Meco MT, Sithanandam G, Rapp UR, Moscat J and Cooper GM: Hydrolysis of phosphatidylcholine couples Ras to activation of Raf protein kinase during mitogenic signal transduction. Mol Cell Biol. 13:7645–7651. 1993. View Article : Google Scholar : PubMed/NCBI
27	Beckman ML, Bernstein EM and Quick MW: Multiple G protein-coupled receptors initiate protein kinase C redistribution of GABA transporters in hippocampal neurons. J Neurosci. 19:RC91999. View Article : Google Scholar : PubMed/NCBI
28	Jayanthi LD, Samuvel DJ, Blakely RD and Ramamoorthy S: Evidence for biphasic effects of protein kinase C on serotonin transporter function, endocytosis, and phosphorylation. Mol Pharmacol. 67:2077–2087. 2005. View Article : Google Scholar : PubMed/NCBI
29	Daniels GM and Amara SG: Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters. J Biol Chem. 274:35794–35801. 1999. View Article : Google Scholar : PubMed/NCBI
30	Gates J Jr, Ferguson SM, Blakely RD and Apparsundaram S: Regulation of choline transporter surface expression and phosphorylation by protein kinase C and protein phosphatase 1/2A. J Pharmacol Exp Therap. 310:536–545. 2004. View Article : Google Scholar
31	Hariparsad N, Carr BA, Evers R and Chu X: Comparison of immortalized Fa2N-4 cells and human hepatocytes as in vitro models for cytochrome P450 induction. Drug Metab Dispos. 36:1046–1055. 2008. View Article : Google Scholar : PubMed/NCBI
32	Ramboer E, Vanhaecke T, Rogiers V and Vinken M: Immortalized human hepatic cell lines for in vitro testing and research purposes. Methods Mol Biol. 1250:53–76. 2015. View Article : Google Scholar : PubMed/NCBI
33	Hu N, Hu M, Duan R, Liu C, Guo H, Zhang M, Yu Y, Wang X, Liu L and Liu X: Increased levels of fatty acids contributed to induction of hepatic CYP3A4 activity induced by diabetes-in vitro evidence from HepG2 cell and Fa2N-4 cell lines. J Pharmacol Sci. 124:433–444. 2014. View Article : Google Scholar : PubMed/NCBI
34	Rumsby M, Schmitt J, Sharrard M, Rodrigues G, Stower M and Maitland N: Human prostate cell lines from normal and tumourigenic epithelia differ in the pattern and control of choline lipid headgroups released into the medium on stimulation of protein kinase C. Br J Cancer. 104:673–684. 2011. View Article : Google Scholar : PubMed/NCBI
35	Bouma ME, Rogier E, Verthier N, Labarre C and Feldmann G: Further cellular investigation of the human hepatoblastoma-derived cell line HepG2: Morphology and immunocytochemical studies of hepatic-secreted proteins. In Vitro Cell Dev Bio. 25:267–275. 1989. View Article : Google Scholar
36	Greene MW, Burrington CM, Lynch DT, Davenport SK, Johnson AK, Horsman MJ, Chowdhry S, Zhang J, Sparks JD and Tirrell PC: Lipid metabolism, oxidative stress and cell death are regulated by PKC delta in a dietary model of nonalcoholic steatohepatitis. PLoS One. 9:e858482014. View Article : Google Scholar : PubMed/NCBI
37	Greene MW, Burrington CM, Ruhoff MS, Johnson AK, Chongkrairatanakul T and Kangwanpornsiri A: PKC{delta} is activated in a dietary model of steatohepatitis and regulates endoplasmic reticulum stress and cell death. J Biol Chem. 285:42115–42129. 2010. View Article : Google Scholar : PubMed/NCBI
38	Nakatsuka A, Matsuyama M, Yamaguchi S, Katayama A, Eguchi J, Murakami K, Tesgigawara S, Ogawa D, Wada N, Yasunaka T, et al: Insufficiency of phosphatidylethanolamine N-methyltransferase is a risk for lean non-alcoholic steatohepatitis. Sci Rep. 6:217212016. View Article : Google Scholar : PubMed/NCBI
39	Yu D, Shu XO, Xiang YB, Li H, Yang G, Gao YT, Zheng W and Zhang X: Higher dietary choline intake is associated with lower risk of nonalcoholic fatty liver in normal-weight Chinese women. J Nutr. 144:2034–2040. 2014. View Article : Google Scholar : PubMed/NCBI
40	Zhou RF, Chen XL, Zhou ZG, Zhang YJ, Lan QY, Liao GC, Chen YM and Zhu HL: Higher dietary intakes of choline and betaine are associated with a lower risk of primary liver cancer: A case-control study. Sci Rep. 7:6792017. View Article : Google Scholar : PubMed/NCBI
41	Roppongi M, Izumisawa M, Terasaki K, Muraki Y and Shozushima M: ¹⁸F-FDG and ¹¹C-choline uptake in proliferating tumor cells is dependent on the cell cycle in vitro. Ann Nucl Med. 33:237–243. 2018. View Article : Google Scholar : PubMed/NCBI